A round up of genomics research is presented in this Telegraph anthology of recent articles from international news sources. Millions of dollars are being funneled into a project to "unlock"  DNA, personal genomics could become second nature, and challenges that have held up the science of genomics and its applications are presented.

The FDA has announced that more than 11,000 lab-driven diagnostic tests that have never been regulated will now fall under the agency's oversight. This includes cancer screening and genetic testing, an area of research that has exploded in the past couple of decades.

IBA (Ion Beam Applications SA), the world's leading provider of proton therapy solutions for the treatment of cancer, announces today that it has received combined clearances from the U.S. Food and Drug Administration (FDA) that will enable IBA to market-launch the Proton Therapy specific Cone Beam Computed Tomography (CBCT) solution.

The University of California San Francisco is creating a magical new world of woodland forests and cable cars in a family friendly molecular imaging and radiology suite, reports SF Gate. 

Based on its recent analysis of the breast imaging systems market, Frost and Sullivan recognizes Gamma Medica with the 2014 Global Frost and Sullivan Award for Product Leadership.

Nematode worms are providing a very, very small window on the neural connections that we humans share. A feature in New Scientist follows the circuitous path of our knowledge about consciousness and the neural networks of the brain.

A feature in The New Yorker explores how Daniela Schiller, PhD, from the Mount Sinai School of Medicine’s Brain Imaging Core in New York City, has approached a kind of memory erasure for people who have suffered greatly from post-traumatic stress disorder (PTSD) with the aid of cutting-edge neuroimaging.

A cutting-edge detector developed by researchers in the United Kingdom and South Africa stands to spark more effective proton therapy for cancer patients.